Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

47.3K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
47.3K
Subviral Agents01:29

Subviral Agents

171
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
171
Retroviruses02:33

Retroviruses

12.8K
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
12.8K
FDA Approved Drugs: Changes to Approved Drugs01:26

FDA Approved Drugs: Changes to Approved Drugs

6
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
6
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

380
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
380
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists01:29

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

528
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
528

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Na<sup>+</sup> detection <i>via</i> brightening of synergistically originated noble metal nanoclusters.

RSC advances·2024
Same author

Comparative Evaluation of the Mechanical Efficiency of Nanosilver Fluoride and Sodium Fluoride Varnish: An <i>In Vitro</i> Study.

International journal of clinical pediatric dentistry·2024
Same author

Novel environmental applications of green tea: sensing and remediation of Ag<sup>+</sup> in aqueous system.

RSC advances·2024
Same author

Assessing the Influence of Patient Anxiety on the Efficacy of Endodontic Procedures.

Journal of pharmacy & bioallied sciences·2024
Same author

Efficiency of Oral Steroids and Steroidal Nasal Spray in Treatment of Chronic Rhinosinusitis: A Comparative Study.

Journal of pharmacy & bioallied sciences·2024
Same author

Antioxidant potential of exopolysaccharides from lactic acid bacteria: A comprehensive review.

International journal of biological macromolecules·2024

Related Experiment Video

Updated: Oct 7, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.6K

Pyrazole Containing Anti-HIV Agents: An Update.

Sanjay Kumar1,2, Shiv Gupta3, Varsha Rani4

  • 1Punjab Biotechnology Incubator, Mohali, Punjab-160071, India.

Medicinal Chemistry (Shariqah (United Arab Emirates))
|January 7, 2022
PubMed
Summary

This review summarizes 220 pyrazole compounds with anti-HIV activity reported over the last two decades. These findings aid in developing novel pyrazole-based drugs for HIV treatment.

Keywords:
AIDSPyrazoleanti-HIVfused-pyrazolepyrazolinepyrazolo

More Related Videos

Synthesis of Antiviral Tetrahydrocarbazole Derivatives by Photochemical and Acid-catalyzed C-H Functionalization via Intermediate Peroxides CHIPS
06:34

Synthesis of Antiviral Tetrahydrocarbazole Derivatives by Photochemical and Acid-catalyzed C-H Functionalization via Intermediate Peroxides CHIPS

Published on: June 20, 2014

14.0K
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

18.0K

Related Experiment Videos

Last Updated: Oct 7, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.6K
Synthesis of Antiviral Tetrahydrocarbazole Derivatives by Photochemical and Acid-catalyzed C-H Functionalization via Intermediate Peroxides CHIPS
06:34

Synthesis of Antiviral Tetrahydrocarbazole Derivatives by Photochemical and Acid-catalyzed C-H Functionalization via Intermediate Peroxides CHIPS

Published on: June 20, 2014

14.0K
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

18.0K

Area of Science:

  • Medicinal Chemistry
  • Organic Chemistry
  • Pharmacology

Background:

  • Pyrazole scaffolds are crucial in drug discovery, exhibiting diverse pharmacological activities.
  • The pyrazole moiety is recognized for its potent anti-Human Immunodeficiency Virus (HIV) properties.
  • This review focuses on pyrazole derivatives as potential therapeutic agents against HIV.

Purpose of the Study:

  • To compile and review pyrazole-containing compounds with reported anti-HIV activity.
  • To provide a comprehensive overview of anti-HIV agents featuring the pyrazole nucleus.
  • To support the ongoing development of novel anti-HIV therapeutics.

Main Methods:

  • Literature search conducted on Google Scholar, PubMed, and SciFinder databases.
  • Searches utilized "pyrazol" keywords, filtered by publication year and "Anti-HIV" designation.
  • Focused on identifying pyrazole derivatives as core structures or substituted forms with anti-HIV activity.

Main Results:

  • A comprehensive compilation of 220 pyrazole-containing compounds with anti-HIV activity is presented.
  • Data sourced from approximately 40 research articles published from 2001 to the present.
  • Specific potent derivatives include mono-, di-, tri-, tetra-, and fused pyrazole types, with notable examples provided.

Conclusions:

  • This review highlights the significant potential of pyrazole derivatives in combating HIV.
  • The compiled information serves as a valuable resource for designing new pyrazole-based anti-HIV compounds.
  • Further research into these derivatives could lead to advanced therapeutic strategies against HIV.